Results 61 to 70 of about 5,515 (141)

IVABRADINE OUTSIDE THE CLINICAL GUIDELINES: INTEREST OF A PRACTITIONER

Российский кардиологический журнал, 2018
The article is focused on the data concerning the influence of ivabradine on myocardial electrophysiology in experimental and clinical studies. It is shown that ivabradine decreases ventricular rate in chronic atrial fibrillation, and prevents the ...
E. I. Tarlovskaya
doaj   +1 more source

Ivabradine in acute heart failure: Effects on heart rate and hemodynamic parameters in a randomized and controlled swine trial

Cardiology Journal, 2020
BACKGROUND: Acute heart failure patients could benefit from heart rate reduction, as myocardial consumption and oxidative stress are related to tachycardia. Ivabradine could have a clinical role attenuating catecholamine-induced tachycardia.
Marina Pascual Izco, Rafael Ramírez-Carracedo, Ignacio Hernández Navarro, Álvaro Osorio Ruiz, Borja Castejón Navarro, Irene Cuadrado Berrocal, Carlota Largo Aramburu, Gonzalo Luis Alonso Salinas, Javier Díez, Marta Saura Redondo, José Luis Zamorano, Carlos Zaragoza, Marcelo Sanmartín   +12 more
doaj   +1 more source

The Effect of Ivabradine on the Heart Rate and Sympathovagal Balance in Postural Tachycardia Syndrome Patients

Rambam Maimonides Medical Journal, 2015
Background: Postural tachycardia syndrome (POTS) is a common form of chronic orthostatic intolerance. The remarkable increase in heart rate (HR) upon standing is the hallmark of this syndrome.
Merav Barzilai, Giris Jacob
doaj   +1 more source

Concomitant Administration of Different Doses of Simvastatin with Ivabradine Influence on PAI-1 and Heart Rate in Normo- and Hypercholesterolaemic Rats

The Scientific World Journal, 2012
Ivabradine is a novel heart rate lowering agent that inhibits If ionic current in the sinus node and demonstrates antiischaemic and antianginal activity.
Jacek Owczarek, Magdalena Jasińska-Stroschein, Daria Orszulak-Michalak   +2 more
doaj   +1 more source

The clinical and economic efficiency of treatment in patients with chronic heart failure

КардиоСоматика, 2013
Objective: to study the clinical and economic benefits of adding ivabradine to standard therapy for chronic heart failure (CHF). Subjects and methods.
E. I Tarlovskaya, S. V Malchikova
doaj  

Comparison between ivabradine and low-dose digoxin in the therapy of diastolic heart failure with preserved left ventricular systolic function

Clinics and Practice, 2013
Multicenter trials have demonstrated that in patients with sinus rhythm ivabradine is effective in the therapy of ischemic heart disease and of impaired left ventricular systolic function. Ivabradine is ineffective in atrial fibrillation.
Giuseppe Cocco, Paul Jerie
doaj   +1 more source

Efficacy of ivabradine in idiopathic dilated cardiomyopathy patients with chronic heart failure

The Egyptian Heart Journal, 2011
Background: The aim of this study was to investigate the effect of ivabradine on symptoms, quality of life, effort tolerance, and echocardiographic parameters in patients with idiopathic dilated cardiomyopathy presenting with New York Heart Association ...
Sherief Mansour, Amr Youssef, Mona Rayan, M. Ayman Saleh   +3 more
doaj   +1 more source

THE ROLE OF PULSE REDUCTION THERAPY IN ADDITIONAL IMPROVEMENT OF CLINICAL EFFECTS OF MYOCARDIAL REVASCULARIZATION IN CORONARY HEART DISEASE STABLE ANGINA PATIENTS

Российский кардиологический журнал, 2018
The review is focused on the role of ivabradine in percutaneous coronary intervention (PCI) and coronary bypass grafting (CBG) in coronary heart disease patients (CHD) with stable angina.
D. M. Aronov, M. G. Bubnova
doaj   +1 more source

ROLE OF HEART RATE REDUCTION WITH IVABRADINE IN LEFT VENTRICULAR FAILURE IVABRADINE AND HEART RATE REDUCTION IN LEFT VENTRICULAR FAILURE

Pakistan Armed Forces Medical Journal, 2020
Objective: To compare mean heart rate reduction in Ivabradine and placebo group in left ventricular failure patients. Study Design: Quasi experimental study.
Safia Batool, Jamal Waris, Muhammad Usman Sajid, Shazia Nisar, Imran Khan, Hina Mushtaq   +5 more
doaj  

Heart rate reduction for 36 months with ivabradine reduces left ventricular mass in cardiac allograft recipients: a long-term follow-up study

Drug Design, Development and Therapy, 2013
Andreas O Doesch,1 Susanne Mueller,1 Christian Erbel,1 Christian A Gleissner,1 Lutz Frankenstein,1 Stefan Hardt,1 Arjang Ruhparwar,2 Philipp Ehlermann,1 Thomas Dengler,3 Hugo A Katus1 1Department of Cardiology, 2Department of Cardiovascular Surgery ...
Doesch AO, Mueller S, Erbel C, Gleissner CA, Frankenstein L, Hardt S, Ruhparwar A, Ehlermann P, Dengler T, Katus HA   +9 more
doaj